things have changed regarding the action of this stock. The stock action of ariad this year, seems to be going against its true value. Despite what would be considered obvious growth and fruition of new medical sciences. The past few years the stock could do no wrong: Lost lawsuit, price moved up. announced dilution(s), price went up. having a potential drug against cancer rejected, price moved up. These events would normally put a hurting on a companies growth and stock value (for quite some time). Now, the more positive news the company puts forward, the more the stock price retreats. Bizarro.
